| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5033552 | Current Opinion in Psychology | 2017 | 19 Pages |
Abstract
Limited efficacy for current pharmacotherapy for PTSD indicates that improved pharmacological treatments are needed. Neurobiological research points to cannabinoids as possible therapeutic agents of interest. Moreover, observational reports indicate that there is growing popular interest in therapeutic use of cannabinoids for the alleviation of trauma symptoms. The aim of this review was to present an up-to-date look at current research on the possible therapeutic value of cannabinoids for PTSD. Experimental, preclinical, and clinical findings are discussed.
Related Topics
Social Sciences and Humanities
Psychology
Applied Psychology
Authors
Mallory JE Loflin, Kimberly A Babson, Marcel O Bonn-Miller,